Nový cíl specifické protinádorové léčby mnohočetného myelomu - endoplazmatické retikulum a jeho signální dráhy

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English The endoplasmic reticulum and its signaling pathways - a novel target for multiple myeloma treatment
Authors

DOSTÁLOVÁ Adéla VLACHOVÁ Monika GREGOROVÁ Jana MORÁŇ Lukáš PEČINKA Lukáš GABRIELOVÁ Viktorie VAŇHARA Petr ŠEVČÍKOVÁ Sabina

Year of publication 2023
Type Article in Periodical
Magazine / Source Klinická onkologie
MU Faculty or unit

Faculty of Medicine

Citation
Web https://www.linkos.cz/casopis-klinicka-onkologie/2023-12-15-6/novy-cil-specificke-protinadorove-lecby-mnohocetneho-myelomu-endoplazmaticke-ret/
Doi http://dx.doi.org/10.48095/ccko2023440
Keywords Multiple myeloma; Endoplasmic reticulum; unfolded protein response
Description Background: The endoplasmic reticulum (ER), an organelle composed of a system of cisternae and tubules, is essential for many cellular processes, including protein synthesis and transport. When misfolded proteins accumulate in the ER lumen, ER stress is induced, and the subsequent response to the disruption of homeostasis is the activation of the unfolded protein response (UPR). The purpose of this process is to restore homeostasis by increasing the capacity of the ER and its ability to fold proteins. Activation of the homeostatic UPR occurs via one of three transmembrane proteins, inositol-requiring enzyme 1a (IRE1a), protein kinase R-like ER kinase (PERK) and activating transcription factor 6 (ATF6). Failure of the attempt to restore homeostasis, on the other hand, leads to the development of terminal UPR and apoptosis via hyperactivation of the same proteins. Activation of UPR has been described in many malignancies, including multiple myeloma (MM), which is characterized by malignant transformation of plasma cells and increased monoclonal immunoglobulin synthesis, where the role of the ER is of particular importance. Despite advances in the treatment of MM, the disease remains difficult to treat and targeting signaling pathways associated with the UPR could, for example, enhance the effect of proteasome inhibitors. Purpose: This review intends to present the molecular response to ER stress under physiological circumstances and in the context of cancer, particularly with regard to potential therapeutic targets in MM.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.